The optimization of cell therapy by combinational application with apicidin-treated mesenchymal stem cells after myocardial infarction

Although mesenchymal stem cells (MSC) have been shown to be safe in preclinical studies of cardiovascular disease, multiple meta-analyses have debated whether functional improvement is significant or not. The cardiac differentiation from MSC is achievable using cardiogenic factors, however, the high...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Cho, Dong Im, Kang, Wan Seok, Hong, Moon Hwa, Kang, Hye Jin, Kim, Mi Ra, Kim, Min Chul, Kim, Yong Sook, Ahn, Youngkeun
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2017
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5546480/
https://ncbi.nlm.nih.gov/pubmed/28498815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.17471
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky